「SARS-CoV-2 Research Using Human Pluripotent Stem Cells and Organoids」の関連論文
-
Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells
-
Editorial: Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy
-
Elucidation of the liver pathophysiology of COVID-19 patients using liver-on-a-chips
-
Cell response analysis in SARS-CoV-2 infected bronchial organoids
-
iPSC-derived mesenchymal cells that support alveolar organoid development
-
iPSC technology-based regenerative medicine for kidney diseases
-
iPSC screening for drug repurposing identifies anti‐RNA virus agents modulating host cell susceptibility
-
STAT3 induces hypoxic preconditioning against oxidative stress in neural stem cells
-
Cell therapy for Parkinson's disease with induced pluripotent stem cells
-
Pluripotent stem cell-based therapies and their path to the clinic
-
StemPanTox: a fast and wide-target drug assessment system for tailor-made safety evaluations using personalized iPS cells
-
Automated measurement of fluorescence signals reveals a significant increase of the graft-derived neurite extension in neonates compared to aged rats
-
Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease
-
An attenuated vaccinia vaccine encoding the severe acute respiratory syndrome coronavirus-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human angiotensin-converting enzyme 2 transgenic mice from severe acute respiratory syndrome coronavirus-2 and its variants
-
Core-shell hydrogel microfiber-expanded pluripotent stem cell-derived lung progenitors applicable to lung reconstruction in vivo
-
Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson’s Disease
-
Establishment of a heart‐on‐a‐chip microdevice based on human iPS cells for the evaluation of human heart tissue function
-
Preparation of hyaluronic acid-coated polymeric micelles for nasal vaccine delivery
-
Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids
-
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
-
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
-
Development of platelet replacement therapy using human induced pluripotent stem cells
-
Quality assessment tests for tumorigenicity of human iPS cell-derived cartilage
-
Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD
-
Production and nonclinical evaluation of an autologous iPSC-derived platelet product for the iPLAT1 clinical trial
-
Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques.
-
Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8⁺ T Cells in Unexposed Individuals
-
Virological characterization of the 2022 outbreak-causing monkeypox virus using human keratinocytes and colon organoids
-
Exocyst complex component 2 is a potential host factor for SARS-CoV-2 infection
-
A disease-specific iPS cell resource for studying rare and intractable diseases
-
Multicellular Modeling of Ciliopathy by Combining iPS cells and Microfluidic Airway-on-a-chip Technology
-
Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC
-
A ROCK Inhibitor Promotes Graft Survival during Transplantation of iPS-Cell-Derived Retinal Cells
-
iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome
-
Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors
-
Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells
-
Simple derivation of skeletal muscle from human pluripotent stem cells using temperature‐sensitive Sendai virus vector
-
Clinical significance of seasonal human coronaviruses in immunocompromised host
-
Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19
-
Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans (本文)
-
Generation of humanized liver in rats
-
SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression
-
Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease
-
Lung fibrogenic microenvironment in mouse reconstitutes human alveolar structure and lung tumor
-
Suppression of Systemic Lupus Erythematosus in NZBWF1 mice infected with Hymenolepis microstoma
-
Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon
-
Disease modeling of pulmonary fibrosis using human pluripotent stem cell-derived alveolar organoids
-
One-step induction of photoreceptor-like cells from human iPSCs by delivering transcription factors
-
Structurally-discovered KLF4 variants accelerate and stabilize reprogramming to pluripotency
-
Studies on Prediction of Cardiotoxicity Induced by Anticancer Drugs and Exploration of Molecular Targets to Prevent Cardiotoxicity